Takeshi Hirasawa

5PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Analytical spectrometry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida

|Dec 16, 2020
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.

Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura

|Aug 23, 2020
Comprehensive Serum Glycopeptide Spectra Analysis Combined with Artificial Intelligence (CSGSA-AI) to Diagnose Early-Stage Ovarian Cancer.

Kazuhiro Tanabe, Masae Ikeda, Masaru Hayashi

|Aug 23, 2020
Utility of Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA) for the Detection of Early Stage Epithelial Ovarian Cancer.

Koji Matsuo, Kazuhiro Tanabe, Masaru Hayashi

|May 01, 2019
Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA): A Potential New Tool for Early Detection of Ovarian Cancer.

Masaru Hayashi, Koji Matsuo, Kazuhiro Tanabe

Pageof 1

Frequent Collaborators

3 joint publications

Mikio Mikami

2 joint publications

Tadashi Imanishi

2 joint publications

Koji Matsuo

2 joint publications

Masae Ikeda